<?xml version="1.0" encoding="UTF-8"?>
<p>The Ag-NPs suspension (75 ppm) exhibited enhanced activity, and recorded the ZOIs of 14.3 ± 1.0, 21 ± 0.9, 16.3 ± 0.5, 20 ± 0.9, and 13.6 ± 0.5 mm corresponded to the pathogenic bacteria 
 <italic>S. aureus</italic>, 
 <italic>B. subtilis</italic>, 
 <italic>P. aeruginosa</italic>, 
 <italic>E. coli</italic>, 
 <italic>and S. typhimurium</italic>, respectively. The highest level of inhibition listed for the maximum bio silver concentration (100 ppm) with ZOIs of 16 ± 0.9, 22.3 ± 1.3, 18 ± 0.9, 21.3 ± 1.2, and 15.3 ± 0.5 mm corresponded to the pathogens 
 <italic>S. aureus</italic>, 
 <italic>B. subtilis</italic>, 
 <italic>P. aeruginosa</italic>, 
 <italic>E. coli</italic>, and 
 <italic>S. typhimurium</italic>, respectively (
 <xref ref-type="fig" rid="antibiotics-09-00641-f005">Figure 5</xref>). Silver nanoparticles derived from the 
 <italic>Streptomyces xinghaiensis</italic> OF1 strain with inhibitory activity against pathogenic fungi and bacteria, including 
 <italic>S. aureus, B. subtilis</italic>, 
 <italic>P. aeruginosa</italic>, and 
 <italic>E. coli</italic> was reported [
 <xref rid="B46-antibiotics-09-00641" ref-type="bibr">46</xref>].
</p>
